Vitamin D Serum Levels in Subjects Tested for SARS-CoV-2: What Are the Differences among Acute, Healed, and Negative COVID-19 Patients? A Multicenter Real-Practice StudySARS-CoV-2 검사 대상자의 비타민 D 혈청 수준: 급성, 치유 및 음성 COVID-19 환자의 차이점은 무엇입니까? 다기관 실제 실습 연구Comparative Study Published on 2021-11-032022-09-10 Journal: Nutrients [Category] MERS, 바이오마커, 진단, [키워드] acting acute COVID-19 administration Admission circulating correlation COVID-19 COVID-19 infection COVID-19 patient COVID-19 patients cytokine deficiency difference dropped evaluate Evidence Gender Gender difference Healed IL-6 IL-6 levels Infection interleukin-6 Level lowest male manifested metabolite multicenter negative non-infected Patient patients pro-inflammatory cytokine recruited reported SARS-CoV-2 secondary endpoint serum Serum level serum levels significant increase significantly lower statistically significant difference subject subjects subset tested three group three groups Vitamin D vitamin D deficiency Vitamin D3 [DOI] 10.3390/nu13113932 PMC 바로가기 [Article Type] Comparative Study
Cardiovascular Abnormalities and Mental Health Difficulties Result in a Reduced Quality of Life in the Post-Acute COVID-19 SyndromeArticle Published on 2021-11-022022-10-28 Journal: Brain Sciences [Category] COVID-19, [키워드] acute COVID-19 acute illness Anxiety average Cardiovascular Abnormality cardiovascular complications characterized correlated COVID-19 Depression diagnosed diastolic difficulty dysfunction evaluated functional HADS impair Increased Inpatient Inpatients intensity life median mental health mental illness Outpatient outpatients Patient physical post-acute COVID-19 pulmonary artery pressure pulmonary injury Quality Quality of life questionnaire reduced reported Result scale Symptom Symptoms symptoms of COVID-19 syndrome TTE [DOI] 10.3390/brainsci11111456 PMC 바로가기 [Article Type] Article
More Than 100 Persistent Symptoms of SARS-CoV-2 (Long COVID): A Scoping ReviewMedicine Published on 2021-11-012022-10-31 Journal: Frontiers in Medicine [Category] COVID-19, [키워드] Abstract acute COVID-19 analysed approaches article case control study Case series categories characterisation Cognitive impairment cohort study concerning conducted Controlled coronavirus disease coronavirus–COVID-19 COVID COVID-19 Cross-sectional studies database described evidenced examined explained Factors fatigue for inclusion forms functional heterogeneity impairment inclusion criteria increasingly independent individual Infection Long Long COVID methodological MOST nine original pandemic participant persistent post acute covid syndrome (PACS) Post-infection Prevalence prospective cohort psychological disorders pulmonary symptoms reported reported symptom reported symptoms respiratory symptoms retrospective review SARS-CoV-2 searched selected Seven significantly Source Spread Study design Symptom Symptoms was performed Web of Science [DOI] 10.3389/fmed.2021.750378 PMC 바로가기 [Article Type] Medicine
Casirivimab/Imdevimab: First Approval카시리비맙/임데비맙: 최초 승인Review Published on 2021-11-012022-09-11 Journal: Drugs [Category] SARS, 신약개발, 진단, [키워드] acute COVID-19 acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 approval Canada Casirivimab causative agent Combination coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 infection COVID-19 treatment eligibility Emergency use authorization Human monoclonal antibody IgG1 Imdevimab Immunoglobulin India Infection Japan Mild Moderate COVID-19 Neutralizing positive Prophylaxis respiratory SARS-CoV-2 severe acute respiratory syndrome Coronavirus Spike protein Switzerland the spike protein Treatment treatment of COVID-19 USA [DOI] 10.1007/s40265-021-01620-z PMC 바로가기 [Article Type] Review
Corrigendum to ‘detection of SARS-CoV-2 N-antigen in blood during acute COVID-19 provides a sensitive new marker and new testing alternatives’Erratum Published on 2021-11-012022-10-05 Journal: Clinical microbiology and infection : the official [Category] 치료기술, [키워드] acute COVID-19 Blood marker provide SARS-CoV-2 N-antigen [DOI] 10.1016/j.cmi.2021.09.034 [Article Type] Erratum
Elevated Anti-SARS-CoV-2 Antibodies and IL-6, IL-8, MIP-1β, Early Predictors of Severe COVID-19Article Published on 2021-10-292022-10-29 Journal: Microorganisms [Category] COVID-19, [키워드] acute COVID-19 acute infection anti-SARS-CoV-2 anti-SARS-CoV-2 antibodies association baseline Concentration COVID-19 COVID-19 patient COVID-19 severity criteria Cytokines cytokines IL-6 Diagnosis disease eight hospitalized COVID-19 patient Host ICU IFN-γ IgA IgG IgG antibodies IgM IL-1β IL-6 IL-8 immune intensive care Laboratory male median age MIP-1α MIP-1β MOST outcome persistence predictor Proinflammatory cytokine SARS-CoV-2 SARS-CoV-2 RNA severe COVID-19 severe COVID-19 disease Symptom Viral load were measured [DOI] 10.3390/microorganisms9112259 PMC 바로가기 [Article Type] Article
Comparison of Persistent Symptoms After COVID-19 and Other Non-SARS-CoV-2 Infections in ChildrenPediatrics Published on 2021-10-292022-10-31 Journal: Frontiers in Pediatrics [Category] COVID-19, [키워드] acute COVID-19 addition affected age anosmia/dysgeusia change children clinical clinical sequelae cognitive cohort study conducted consequence controls coughing COVID COVID patient COVID-19 COVID-19 patient cut-off difference enrolled etiologies fatigue Fever follow-up time group headache Headaches identify Inclusion Infection IQR irritability Latvia less long-lasting loss of taste majority MOST nocturnal Other Patient pediatric pediatrics persistence persistent regression analysis reported Research rhinorrhea SARS-CoV-2 SARS-COV-2 infection significantly study population survivor sweating Symptom symptom onset Symptoms the patient university Viral with COVID-19 [DOI] 10.3389/fped.2021.752385 PMC 바로가기 [Article Type] Pediatrics
Sinus Bradycardia in a Pediatric Patient Treated With Remdesivir for Acute Coronavirus Disease 2019: A Case Report and a Review of the Literature급성 코로나바이러스 질환 2019에 대해 렘데시비르로 치료받은 소아 환자의 부비동 서맥: 증례 보고 및 문헌 검토Review Published on 2021-10-272022-09-11 Journal: Journal of the Pediatric Infectious Diseases Socie [Category] SARS, 치료제, [키워드] acute COVID-19 acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 adverse event bradycardia coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 literature MOST Patient pediatric pediatrics Remdesivir report reported review RNA polymerase inhibitor SARS-CoV-2 Severe acute respiratory syndrome severe acute respiratory syndrome Coronavirus Side effect Sinus sinus bradycardia spreads the patient therapy treated Treatment [DOI] 10.1093/jpids/piab029 PMC 바로가기 [Article Type] Review
Cardiac involvement in the long-term implications of COVID-19 Reviews Published on 2021-10-222022-10-05 Journal: Nature reviews. Cardiology [Category] COVID19(2023년), SARS, 바이오마커, 임상, 치료법, [키워드] acute COVID-19 addressed approval benefit cardiac caused Consequences coronavirus disease COVID-19 highlight implication mitigate MONITOR morbidity and mortality pandemic Patient Prospective Study question resource Scientific community survived survivor Survivors syndrome Vaccines [DOI] 10.1038/s41569-021-00631-3 [Article Type] Reviews
The Fall in Antibody Response to SARS-CoV-2: a Longitudinal Study of Asymptomatic to Critically Ill Patients Up to 10 Months after RecoverySARS-CoV-2에 대한 항체 반응 감소: 회복 후 최대 10개월까지 중환자에 대한 무증상 환자에 대한 종단 연구Article Published on 2021-10-192022-09-12 Journal: Journal of Clinical Microbiology [Category] MERS, SARS, 진단, [키워드] acute COVID-19 acute respiratory syndrome age Antibody Response conducted coronavirus coronavirus disease COVID-19 declined Effect Factor female First wave Follow-up IgG IgG antibody IgM IgM antibody Ill Immunity independent predictor individual initial intensity interquartile range Italy Linear regression longitudinal longitudinal study. median Mild Month number of symptom Outpatient Patient Primary infection response SARS-CoV-2 SARS-CoV-2 antibodies SARS-CoV-2 IgG SARS-CoV-2 IgM SARS-CoV-2 serology seroconversion rate serological serological response seroreversion severity the disease [DOI] 10.1128/JCM.01138-21 PMC 바로가기 [Article Type] Article